Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents

An Examination of Access for All Women

Megan L. Evans, Eve Espey, Tony Ogburn, Nikki Zite

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Although long-acting reversible contraception (LARC) use is increasing in the general female population, only 12% of all women who use contraception and 4.8% of nulliparous women in the United States use either the intrauterine device (IUD) or contraceptive implant. In several studies, however, female physicians prefer LARC for contraception. In 2016, an anonymous electronic survey was administered to all U.S. obstetrics and gynecology residents before the start of the annual in-training examination administered by the Council on Resident Education in Obstetrics and Gynecology. The survey included questions about LARC, including personal use. Fifty percent of female residents or the female partners of male residents used IUDs for contraception, 31.3% used combined oral contraceptives, and 3% used a contraceptive implant. Among nulliparous residents, 37.7% used IUDs. This rate of IUD use was five times the rate reported by the general female population and eight times the nulliparous rate in the United States. Obstetrics and gynecology residents understand the benefits of LARC, but have minimal barriers to access. When barriers and cost are removed and the full range of contraceptive options is offered, the majority of contracepting women and adolescents choose LARC. With the high rates of unintended pregnancy and maternal morbidity and mortality in the United States—especially among poor and minority women—all women, regardless of income, race–ethnicity, and career, should have awareness of and access to these effective contraceptive methods.

Original languageEnglish (US)
Pages (from-to)538-541
Number of pages4
JournalObstetrics and gynecology
Volume131
Issue number3
DOIs
StatePublished - Jan 1 2018

Fingerprint

Gynecology
Contraception
Obstetrics
Intrauterine Devices
Contraceptive Agents
Contraceptives, Oral, Combined
Maternal Mortality
Pregnancy Rate
Population
Morbidity
Physicians
Education
Costs and Cost Analysis

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents : An Examination of Access for All Women. / Evans, Megan L.; Espey, Eve; Ogburn, Tony; Zite, Nikki.

In: Obstetrics and gynecology, Vol. 131, No. 3, 01.01.2018, p. 538-541.

Research output: Contribution to journalArticle

@article{db90891ef302439a8fcfe38323c60bde,
title = "Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents: An Examination of Access for All Women",
abstract = "Although long-acting reversible contraception (LARC) use is increasing in the general female population, only 12{\%} of all women who use contraception and 4.8{\%} of nulliparous women in the United States use either the intrauterine device (IUD) or contraceptive implant. In several studies, however, female physicians prefer LARC for contraception. In 2016, an anonymous electronic survey was administered to all U.S. obstetrics and gynecology residents before the start of the annual in-training examination administered by the Council on Resident Education in Obstetrics and Gynecology. The survey included questions about LARC, including personal use. Fifty percent of female residents or the female partners of male residents used IUDs for contraception, 31.3{\%} used combined oral contraceptives, and 3{\%} used a contraceptive implant. Among nulliparous residents, 37.7{\%} used IUDs. This rate of IUD use was five times the rate reported by the general female population and eight times the nulliparous rate in the United States. Obstetrics and gynecology residents understand the benefits of LARC, but have minimal barriers to access. When barriers and cost are removed and the full range of contraceptive options is offered, the majority of contracepting women and adolescents choose LARC. With the high rates of unintended pregnancy and maternal morbidity and mortality in the United States—especially among poor and minority women—all women, regardless of income, race–ethnicity, and career, should have awareness of and access to these effective contraceptive methods.",
author = "Evans, {Megan L.} and Eve Espey and Tony Ogburn and Nikki Zite",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/AOG.0000000000002489",
language = "English (US)",
volume = "131",
pages = "538--541",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents

T2 - An Examination of Access for All Women

AU - Evans, Megan L.

AU - Espey, Eve

AU - Ogburn, Tony

AU - Zite, Nikki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Although long-acting reversible contraception (LARC) use is increasing in the general female population, only 12% of all women who use contraception and 4.8% of nulliparous women in the United States use either the intrauterine device (IUD) or contraceptive implant. In several studies, however, female physicians prefer LARC for contraception. In 2016, an anonymous electronic survey was administered to all U.S. obstetrics and gynecology residents before the start of the annual in-training examination administered by the Council on Resident Education in Obstetrics and Gynecology. The survey included questions about LARC, including personal use. Fifty percent of female residents or the female partners of male residents used IUDs for contraception, 31.3% used combined oral contraceptives, and 3% used a contraceptive implant. Among nulliparous residents, 37.7% used IUDs. This rate of IUD use was five times the rate reported by the general female population and eight times the nulliparous rate in the United States. Obstetrics and gynecology residents understand the benefits of LARC, but have minimal barriers to access. When barriers and cost are removed and the full range of contraceptive options is offered, the majority of contracepting women and adolescents choose LARC. With the high rates of unintended pregnancy and maternal morbidity and mortality in the United States—especially among poor and minority women—all women, regardless of income, race–ethnicity, and career, should have awareness of and access to these effective contraceptive methods.

AB - Although long-acting reversible contraception (LARC) use is increasing in the general female population, only 12% of all women who use contraception and 4.8% of nulliparous women in the United States use either the intrauterine device (IUD) or contraceptive implant. In several studies, however, female physicians prefer LARC for contraception. In 2016, an anonymous electronic survey was administered to all U.S. obstetrics and gynecology residents before the start of the annual in-training examination administered by the Council on Resident Education in Obstetrics and Gynecology. The survey included questions about LARC, including personal use. Fifty percent of female residents or the female partners of male residents used IUDs for contraception, 31.3% used combined oral contraceptives, and 3% used a contraceptive implant. Among nulliparous residents, 37.7% used IUDs. This rate of IUD use was five times the rate reported by the general female population and eight times the nulliparous rate in the United States. Obstetrics and gynecology residents understand the benefits of LARC, but have minimal barriers to access. When barriers and cost are removed and the full range of contraceptive options is offered, the majority of contracepting women and adolescents choose LARC. With the high rates of unintended pregnancy and maternal morbidity and mortality in the United States—especially among poor and minority women—all women, regardless of income, race–ethnicity, and career, should have awareness of and access to these effective contraceptive methods.

UR - http://www.scopus.com/inward/record.url?scp=85047725024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047725024&partnerID=8YFLogxK

U2 - 10.1097/AOG.0000000000002489

DO - 10.1097/AOG.0000000000002489

M3 - Article

VL - 131

SP - 538

EP - 541

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -